Skip to Content
Merck
CN

G9664

FreAlagin R gelatin

lyophilized powder

Synonym(s):

Gelatin from porcine skin

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

CAS Number:
EC Number:
232-554-6
UNSPSC Code:
12352202
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

Porcine skin

sterility

aseptically processed

form

lyophilized powder

mol wt

200-10,000

technique(s)

ELISA: suitable, cell culture | mammalian: suitable, immunocytochemistry: suitable, western blot: suitable

impurities

endotoxin, tested

storage temp.

2-8°C

General description

FreAlagin gelatins are non-antigenic and low allergenic. They are recommended for use as stabilizers or blocking reagents.

Other Notes

Gelatin is a heterogeneous mixture of water-soluble proteins of high average molecular masses, present in collagen. Proteins are extracted by boiling the relevant skin, tendons, ligaments, bones, etc. in water. Type A gelatin is derived from acid-cured tissue. Type B is derived from lime-cured tissue.

Legal Information

FreAlagin is a trademark of Miyagi Chemical Industries Co., Ltd.

Storage Class

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Dai-Hung Ngo et al.
Food chemistry, 143, 246-255 (2013-09-24)
Skin gelatin of skate (Okamejei kenojei) was hydrolyzed using Alcalase, flavourzyme, Neutrase and protamex. It was found that the Alcalase hydrolysate exhibited the highest angiotensin-I converting enzyme (ACE) inhibitory activity. Then, Alcalase hydrolysate was further hydrolyzed with protease and separated
Shutaro Gunji et al.
Surgery, 154(5), 991-999 (2013-09-07)
Peritoneal carcinomatosis is a poor prognostic factor for patients with gastrointestinal, gynecologic, and pancreatic cancer. Cisplatin (CDDP) is among the most effective anti-cancer agents, although its adverse effects remain unresolved. For the treatment of peritoneal carcinomatosis with high-dose CDDP, it
L Du et al.
Poultry science, 92(9), 2463-2474 (2013-08-21)
Gelatins were prepared from chicken and turkey heads in a series of batch extractions at 2 different temperatures (50 and 60°C), and their composition and functional properties were evaluated. Gelatin yield from chicken and turkey heads was 52.29 and 62.76%
Claudio Schonauer et al.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 13 Suppl 1, S89-S96 (2004-06-29)
The use of local agents to achieve hemostasis is an old and complex subject in surgery. Their use is almost mandatory in spinal surgery. The development of new materials in chemical hemostasis is a continuous process that may potentially lead
Mitsumasa Kawago et al.
The Journal of thoracic and cardiovascular surgery, 147(5), 1644-1649 (2013-09-12)
Intra-airway and intra-arterial administration of gelatin-embedded, sustained-release basic fibroblast growth factor has stimulated regeneration of emphysematous lungs in animal experiments, but these routes of administration may also cause harm. This study investigated the effectiveness of intrapleural administration of gelatin-embedded, sustained-release

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service